Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The EURODIAB IDDM Complications Study involved the examination of 3250 randomly selected insulin-dependent diabetic patients, from 31 centres in 16 European countries. Part of the examination included an assessment of neurological function including neuropathic symptoms and physical signs, vibration perception threshold, tests of autonomic function and the prevalence of impotence. The prevalence of diabetic neuropathy across Europe was 28% with no significant geographical differences. Significant correlations were observed between the presence of diabetic peripheral neuropathy with age (p < 0.05), duration of diabetes (p < 0.001), quality of metabolic control (p < 0.001), height (p < 0.01), the presence of background or proliferative diabetic retinopathy (p < 0.01), cigarette smoking (p < 0.001), high-density lipoprotein cholesterol (p < 0.001) and the presence of cardiovascular disease (p < 0.05), thus confirming previous associations. New associations have been identified from this study - namely with elevated diastolic blood pressure (p < 0.05), the presence of severe ketoacidosis (p < 0.001), an increase in the levels of fasting triglyceride (p < 0.001), and the presence of microalbuminuria (p < 0.01). All the data were adjusted for age, duration of diabetes and HbA1c. Although alcohol intake correlated with absence of leg reflexes and autonomic dysfunction, there was no overall association of alcohol consumption and neuropathy. The reported problems of impotence were extremely variable between centres, suggesting many cultural and attitudinal differences in the collection of such information in different European countries. In conclusion, this study has identified previously known and new potential risk factors for the development of diabetic peripheral neuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, even in more contemporary cohorts with recent-onset T2D prevalence rates of up to 25% have been observed,545,546 including in youth417,612–615 or at different degrees of glucose intolerance.616”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [545]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Young, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Dyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482
The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes
Ewing, D. J., Martyn, C. N., Young, R. J., & Clarke, B. F. (1985) · Diabetes Care · doi:10.2337/diacare.8.5.491 · Cited by 1,434 · cited 1×
“1) the presence of one or more symptoms; 2) absence of two or more ankle or knee reflexes; 3) vibration perception threshold which was abnormal relating to age-related measures [12] and 4) abnormal autonomic function assessed using Ewing’s definitons [13] of postural hypotension with a fall in systolic blood pressure…”
MethodPirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.3.168 · Cited by 1,290
Maser, R. E., Steenkiste, A. R., Dorman, J. S., Nielsen, V. K., Bass, E. B., Manjoo, Q., Drash, A. L., Becker, D. J., Kuller, L. H., Greene, D. A., et al. (1989) · Diabetes · doi:10.2337/diab.38.11.1456 · Cited by 408
Pirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.4.252 · Cited by 358
Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study
Stephenson, J., Fuller, J. H., & EUROBIAB IDDM Complications Study Group (1994) · Diabetologia · doi:10.1007/bf00398055 · Cited by 345
Self-citationReport and Recommendations of the San Antonio Conference on Diabetic Neuropathy
(1988) · Diabetes · doi:10.2337/diab.37.7.1000 · Cited by 308
Malik, R. A., Newrick, P. G., Sharma, A. K., Jennings, A., Ah-See, A. K., Mayhew, T. M., Jakubowski, J., Boulton, A. J. M., & Ward, J. D. (1989) · Diabetologia · doi:10.1007/bf00505180 · Cited by 294
Self-citationSENSORY NEUROPATHY IN NON-INSULIN-DEPENDENT DIABETES MELLITUS
FRANKLIN, G. M., KAHN, L. B., BAXTER, J., MARSHALL, J. A., & HAMMAN, R. F. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115547 · Cited by 281
Cited by
Items 401–500 of 693
Levterova, B. A., Naydenov, V., Todorov, P., & Levterov, G. (2018) · Trakia Journal of Sciences · doi:10.15547/tjs.2018.s.01.015 · Cited by 11
Taheri, A., Farbood, A., Heshmat, R., Samadi, A., Khashayar, P., Qorbani, M., Ghorbani, M., & Khaneqah, G. E. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0217-3 · Cited by 10
“using pharmacological and non-pharmacological agents, and to preserve good glycemic control [21].”
BackgroundMethodDiabetes and cervical myelopathy
Houten, J. K., & Lenart, C. J. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.07.025 · Cited by 12
“Scientific evidence is accumulating that diabetes causes ischemic changes in the spinal cord in a manner comparable with that known to occur in both the peripheral nerves and brain [14,15].”
Diagnosis and Management of Diabetic Peripheral Neuropathy
Illa, I. (1999) · European Neurology · doi:10.1159/000052073 · Cited by 10
“Epidemiology of DPNThe quantification of the prevalence of DPN is controversial. Estimates of the prevalence of DPN reported by published studies vary. The discrepancy may be explained by the variety of diagnostic criteria and tests used in different studies and also by the prevalence of undiagnosed diabetes in the ge…”
BackgroundNatural therapy proposed for the management of diabetic peripheral neuropathy (DPN)
Merghany, R. M., Saleh, R. A., Hamed, A. A., El‐Dessouki, A. M., El‐Shiekh, R. A., Zaki, E. M., & Mahfoz, A. M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01790-2 · Cited by 11
Clinical Management of Diabetic Ulcers
Thomas, D. R. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.01.007 · Cited by 10
Correlates of diabetic polyneuropathy of the elderly in Sub-Saharan Africa
Simo, N., Kuate-Tegueu, C., Ngankou, S., Doumbe, J. N., Maiga, Y. M., Cesari, M., Dartigues, J., Kengne, A. P., & Tabué-Teguo, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240602 · Cited by 11
“It had already been stated that polyneuropathy was also related to specific diabetes micro-vascular problems like retinopathy [34].”
BackgroundHu, A., & Teo, M. R. (2020) · Proceedings of Singapore Healthcare · doi:10.1177/2010105820978993 · Cited by 11
Painful diabetic polyneuropathy: evidence-based diagnosis and treatment
Khramilin, V. N., & Давыдов, О. С. (2021) · Russian Journal of Pain · doi:10.17116/pain20211904144 · Cited by 10
A Progressive Late Complication in Diabetic Distal Symmetric Polyneuropathy
Andreassen, C. S., Jakobsen, J., & Andersen, H. (2006) · Cited by 9
Dangew, L. B., & Muluneh, E. K. (2017) · Ethiopian Journal of Science and Technology · doi:10.4314/ejst.v10i1.5 · Cited by 9
“…in 28 countries across four continents (Asia, Africa, Europe and South America) by Litwak et al. (2013) and several other works in different parts of the world are in line with this finding (Tesfaye et al. 1996; Wändell 1999; Moore et al., 2009; Bansal et al., 2014; Svensson et al., 2015).”
ResultClinical Features of Diabetic Polyneuropathy
Tesfaye, S. H. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-311-0_14 · Cited by 9
Self-citationType 2 diabetes mellitus: Link between diet, HbA1c and complications
Sami, W., & Ansari, T. (2016) · Australasian Medical Journal · doi:10.4066/amj.2016.2708 · Cited by 16
Panthi, S., Jing, X., Gao, C., & Gao, T. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1927-5 · Cited by 9
“According to the EURODIAB IDDM Complications Study, the prevalence rate of DPN across Europe was 28% [2].”
MethodNoh, S. U., Lee, W., Kim, W., Lee, Y., & Yoon, K. J. (2018) · Molecular Pain · doi:10.1177/1744806918775482 · Cited by 9
Going beyond the ‘grand mean’: Advancing disease management science and evidence
Elissen, A. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20130425ae · Cited by 16
Pető, A., Tóth, L. I., Hernyák, M., Lőrincz, H., Molnár, Á., Nagy, A. C., Lukács, M., Kempler, P., Paragh, G., Harangi, M., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306482 · Cited by 9
Diagnosis of Diabetic Neuropathy
Veves, A. (1998) · Humana Press eBooks · doi:10.1007/978-1-4612-1816-6_4 · Cited by 8
I Diretriz sobre Aspectos Específicos de Diabetes (tipo 2) Relacionados à Cardiologia
Gualandro, D., Azevedo, F., Calderaro, D., Marcondes‐Braga, F. G., Caramelli, B., Schaan, B. D., Soeiro, A., Mansur, A. D. P., Rochitte, C. E., Junior, C. V. S., et al. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2014s002 · Cited by 17
Hansen, C. S., Rasmussen, D. G. K., Hansen, T. W., Nielsen, S. H., Theilade, S., Karsdal, M. A., Genovese, F., & Rossing, P. R. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01891-8 · Cited by 10
“Estimates suggests that 20% of people with type 1 diabetes have signs of DSPN 20 years after diabetes diagnosis [10, 11].”
BackgroundManagement of Diabetic Peripheral Neuropathy
Kang, M. S., & Kim, C. H. (2015) · Korean Journal of Medicine · doi:10.3904/kjm.2015.89.3.277 · Cited by 9
Effects of Experimental Diabetes on C/EBP Proteins in Rat Hippocampus, Sciatic Nerve and Ganglia
Kazkayası, İ., Burul-Bozkurt, N., Onder, S. C., Kelicen‐Uğur, P., & Pekiner, C. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9924-9 · Cited by 8
“Chronic hyperglycemia is the main pathogenic factor in the development and progression of this complication that may be retarded by strict glycemic control (Tesfaye et al. 1996; Amthor et al. 1994; Obrosova 2009; ter Laak et al. 2000).”
BackgroundNeuropatía diabética y pie diabético
Vázquez, F., Mauricio, D., & Julià, J. V. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.09.004 · Cited by 19
Clinical features and diagnosis of diabetic polyneuropathy
Sé, A., Chernenkova, N. A., & Сурнина, З. В. (2017) · Russian Annals of Ophthalmology · doi:10.17116/oftalma2017133598-102 · Cited by 8
“ДСПН существенно повышает смертность и распространенность сердечно-сосудистых заболеваний, а также трофических нарушений [8].”
Riguetto, C. M., Takano, C. R., Admoni, S. N., Parisi, M. C. R., Corrêa‐Giannella, M. L., Pavin, E. J., & Neto, A. M. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00467-2 · Cited by 8
Khan, M., Joshi, D. S., & Singh, A. K. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_231_20 · Cited by 12
“Sensory neuropathy is usually the earliest to develop as reported in various epidemiological studies.[29,30] The same is reflected in the higher proportion of sensory only neuropathy seen in this study among those with milder grades of retinopathy as compared to combined motor and sensory neuropathy in the higher grad…”
BackgroundLong-Term Conditions: Nursing Care and Management
Meerabeau, L., & Wright, K. (2011) · Andalas University Repository (Andalas University) · Cited by 11
Relationship of Vascular Factors on Electrophysiologic Severity of Diabetic Neuropathy
Hwang, J.-W., Pyun, S., & Kwon, H.-K. (2016) · Annals of Rehabilitation Medicine · doi:10.5535/arm.2016.40.1.56 · Cited by 8
“[31] had an assertion that DPN had a close relationship with other diabetic complications, it supported the existence of a common pathological mechanism as being the cause of development of diabetic complications.”
BackgroundDiabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_10 · Cited by 13
Jude, E. B., & Boulton, A. J. M. (1999) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/s0891-8422(23)00936-9 · Cited by 8
The role of healthy lifestyles in preventing chronic disease among adults
Tan, X. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.04.007 · Cited by 7
Azarboo, A., Fallahtafti, P., Javidan, A., Zareshahi, N., Giglou, H. S., Moayyed, S., Raeini, A. G., & Hemmatabadi, M. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103223 · Cited by 8
Painful Diabetic Neuropathy in Clinical Practice
Boulton, A. J. M., & Vileikytė, L. (2011) · Springer eBooks · doi:10.1007/978-0-85729-488-3 · Cited by 7
An overview of optometrists' diabetic retinopathy practice patterns – a cross‐sectional survey
Tang, V. T. S., Symons, R. C. A., Guest, D. J., & McKendrick, A. M. (2021) · Ophthalmic and Physiological Optics · doi:10.1111/opo.12798 · Cited by 7
“Manifest diabetic retinopathy is closely linked to peripheral neuropathy 36-38 and nephropathy, 39,40 as well as positively associated with mortality and cardiovascular events.”
Diabetic Neuropathy: Prevalence and Impact on Quality of Life in Al-Ahsa, Saudi Arabia
Alhajji, A. M., Alkhlaif, Z. K., Bukhamsin, S. A. A., Alkhars, F. S., & Hussaini, H. A. A. (2022) · Cureus · doi:10.7759/cureus.33176 · Cited by 9
“Another study assessed the prevalence of type 1 DM complications in many European countries and found that the prevalence of DN was about 28% [14], which is much lower than the frequency of DN identified in our study patients.”
BackgroundRenno, W. M., Saleh, F., Klepáček, I., & Al-Awadi, F. M. (2006) · PubMed · Cited by 7
Painful diabetic neuropathy — current understanding and management for the primary care team
Kirby, M. G. (2003) · The British Journal of Diabetes · doi:10.1177/14746514030030021001 · Cited by 7
Xiong, W., Feng, X., Liu, J., & Chen, W. (2016) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2016.06.002 · Cited by 7
Scaria, A., Kamath, J. V., & Chakraborty, M. (2017) · International Journal of Ayurvedic Medicine · doi:10.47552/ijam.v8i4.1025 · Cited by 7
Diabetes and Long-Term Complications
Cagliero, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00051-2 · Cited by 11
Wegeberg, A., Meldgaard, T., Hyldahl, S., Jakobsen, P. E., Drewes, A. M., Brock, B., & Brock, C. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i2.87 · Cited by 8
Peripheral and Autonomic Neuropathy in Diabetes
Pop‐Busui, R., Boulton, A. J. M., & Sosenko, J. M. (2018) · Cited by 12
At-Risk Drinking among Diabetic Patients
Ramsey, S. E., & Engler, P. A. (2009) · Substance Abuse Research and Treatment · doi:10.4137/sart.s2243 · Cited by 9
Wysocka‐Mincewicz, M., Baszyńska–Wilk, M., Mazur, M., Byczyńska, A., & Nowacka-Gotowiec, M. (2021) · Metabolites · doi:10.3390/metabo11110795 · Cited by 6
“Results of our study are compatible with previous studies that weight, height, BMI, and BMI Z-score are significant vital risk factors for peripheral nerves damage [21,22].”
ResultFactores de riesgo y pie diabético
Borge, V. M., de la Morena, L. H., Castro-Dufourny, I., Martínez, A. F., & Sánchez, L. F. P. (2007) · Anales de Medicina Interna · doi:10.4321/s0212-71992007000600002 · Cited by 16
“Existe evidencia clínica de que la aparición de las complicaciones microvasculares de la diabetes como la retinopatía, la nefropatía o la neuropatía está en relación con el control metabólico (2-4).”
BackgroundEpidemiology and Health Care Cost of Diabetic Foot Problems
Frykberg, R. G., Cook, J. J., & Simonson, D. C. (2018) · Contemporary diabetes · doi:10.1007/978-3-319-89869-8_1 · Cited by 7
Li, C., Anne, E., & John, J. (2013) · InTech eBooks · doi:10.5772/55364 · Cited by 7
“weight and height) interact with diabetes and make for strong predictors of neurological decline [13, 32, 40-42].”
Signal Transduction Therapy of Diabetic Vascular Complication
Yamagishi, S., Nakamura, K., Matsui, T., Yoshida, Y., Takenaka, K., Jinnouchi, Y., & Imaizumi, T. (2007) · Current Signal Transduction Therapy · doi:10.2174/157436207779317100 · Cited by 6
PREVALENCE OF SENSORY NEUROPATHY IN TYPE 2 DIABETIC PATIENTS IN IRANIAN POPULATION (YAZD PROVINCE)
A.A.Gh., R., Mohammad, A. A., Souzani, A., Mozhgan, M., & Mashahiri, M. R. (2009) · Iranian journal of diabetes and obesity · Cited by 6
Chun, J.-H., & Hong, J. (2015) · Journal of Physical Therapy Science · doi:10.1589/jpts.27.2697 · Cited by 6
Tesfaye, S. H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-075-1_6 · Cited by 6
Self-citationWang, L., Li, J., Lin, Y., Yuan, H., Fang, Z., Fei, A., Shen, G.-M., & Jiang, A. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01728-9 · Cited by 8
“Diabetes duration was positively correlated with the incidence of DPN in this analysis, consistent with prior evidence linking poor glycemic control and diabetes duration to microvascular complications [21].”
ResultReduced Ia-Afferent-Mediated Hoffman Reflex in Streptozotocin-Induced Diabetic Rats
Tonra, J. R., Cliffer, K. D., Carson, S. R., Lindsay, R. M., Bodine, S. C., & DiStefano, P. S. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7767 · Cited by 5
Specific features of urogenital disorders in patents with diabetes mellitus
Rozhivanov, R. V., Akimova, A. N., Dubsky, S., Курбатов, Д. Г., & Dedov, I. I. (2009) · Diabetes Mellitus · doi:10.14341/2072-0351-5396 · Cited by 6
Capsaicina tópica en el tratamiento del dolor neuropático
Vidal, M. A., Calderón, E. J., Román, D. S., Pérez-Bustamante, F. J., & Torres, L. M. (2004) · Hispana · Cited by 5
The EURODIAB Prospective Complications Study
Gruden, G., Barutta, F., Chaturvedi, N., Schalkwijk, C. G., Stehouwer, C. D. A., Witte, D. R., Fuller, J., Perin, P. C., & Bruno, G. (2012) · Cited by 5
Self-citationWeiswasser, J. M., Arora, S., Shuman, C. R., Kellicut, D. C., & Sidawy, A. N. (2003) · Seminars in Vascular Surgery · doi:10.1016/s0895-7967(03)70005-2 · Cited by 7
Pérez, C. M. A. R. G. C., Margarit, C., & Gálvez, R. (2011) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s7398 · Cited by 6
Ab, F., Na, A., Sn, A., Faa, A., Mza, H., & Norlaila, M. (2010) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) · Cited by 5
Légrády, P., Bajcsi, D., Lengyel, C., Várkonyi, T. T., Fejes, I., Kempler, P., & Ábrahám, G. (2013) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2012.758272 · Cited by 5
Treatment of Diabetic Neuropathy
Pop‐Busui, R., Simmons, Z., & Feldman, E. L. (2010) · Wiley eBooks · doi:10.1002/9780470682807.ch19 · Cited by 6
Elzehery, R. R., El-Hafez, H. A. A., Elsehely, I., Barakat, A. F., Foda, E. A., Hendawy, S. R., Gameil, M. A., Nada, H. S., & El-Sebaie, A. H. (2024) · Gene · doi:10.1016/j.gene.2024.148525 · Cited by 4
Balogun, W., Emuze, M. E., Adebusoye, L. A., & Olowookere, O. O. (2024) · Geriatric Care · doi:10.4081/gc.2024.12308 · Cited by 6
Gad, H., Elgassim, E., Mohamud, K., Al‐Naimi, N. S., Al-Sharshani, H., Mohammed, I., Al-Malaheem, M. A. O., Quadros, D. J., AlJalahma, A., Lamine, N., et al. (2025) · Journal of the Peripheral Nervous System · doi:10.1111/jns.70026 · Cited by 4
Early diagnosis of neuropathy in diabetic patients using nerve conduction studies
Parkhad, S., & Palve, S. (2013) · National Journal of Physiology Pharmacy and Pharmacology · doi:10.5455/njppp.2014.4.041220132 · Cited by 4
Baker, N. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03731.x · Cited by 4
Kvalsund, M. P., Chidumayo, T., Hamel, J., Herrmann, D. N., Heimburger, D. C., Peltier, A., & Birbeck, G. L. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.02.035 · Cited by 4
Height is a risk factor for development of peripheral insensate neuropathy
Sujjay, J., Green, S. R., & Mohamed Kasim, A. (2019) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20192253 · Cited by 4
“Height was not associated with painful neuropathy.(1,2,4,24)”
BackgroundResultSudhan, P., Subbiah, B., Sukumaran, R., Janaki, G., Nagesh, P., & Kalpana, L. (2022) · International Journal of Life Science and Pharma Research · doi:10.22376/ijlpr.2023.13.1.l230-244 · Cited by 4
Mateen, S., & Kwaadu, K. Y. (2023) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2023.05.004 · Cited by 4
Kamiya, H., Himeno, T., Watarai, A., Baba, M., Nishimura, R., Tajima, N., & Nakamura, J. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14105 · Cited by 4
“In the present study, triglycerides and smoking history were not signi fi cant risk factors for DSPN, whereas they were positive risk factors for DSPN in the previous study 19 .”
BackgroundResultThe clinical management of diabetic foot in the elderly and medico-legal implications
Terranova, C., & Bruttocao, A. (2013) · Medicine Science and the Law · doi:10.1177/0025802412473595 · Cited by 7
Surgical Equinus Correction for the Diabetic Charcot Foot
Capobianco, C. M. (2016) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2016.07.005 · Cited by 5
“The European Diabetes Centers study of insulin-dependent diabetic patients (n 5 3250) showed a prevalence of neuropathy in 28% of patients.(7)”
BackgroundS., V. M., Lakshmanan, S., & Anbazhagan, R. (2018) · International Surgery Journal · doi:10.18203/2349-2902.isj20184617 · Cited by 4
“Diabetic neuropathy is common accompanying factor in almost 90% of diabetic foot ulcers.(5) About 80% of”
BackgroundPrevalence of risk factors promoting Diabetic neuropathy .
Qadir, A., Sohail, S., Naz, L., Yasmeen, G., & Iqbal, N. (2019) · Pakistan Journal of Neurological Sciences · Cited by 6
The Validity and Reliability of the Turkish Version of the Toronto Clinical Scoring System
Kaymaz, S., Köylü, S. U., KAYMAZ, T. İ., & Aykan, S. A. (2019) · Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi · doi:10.31609/jpmrs.2019-65511 · Cited by 4
Prevalence and Risk Factors of Peripheral Neuropathy among Diabetic Patients in Aden Diabetic Center
EBRAHIM, M. D. L. M. H. B. A. B. A. A., & HANAN Sh. MOHAMMED, M. D. (2019) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2019.59333 · Cited by 4
Association of insulin treatment with gastric residue during an esophagogastroduodenoscopy
Kobori, T., Onishi, Y., Iwamoto, M., Kubota, T., Kikuchi, T., Tahara, T., Takao, T., Fujiwara, H., Yoshida, Y., & Kasuga, M. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13665 · Cited by 4
Impact of Painful Diabetic Polyneuropathy on Patients
Tesfaye, S. H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6299-6_13 · Cited by 4
Self-citationNeuropatía diabética: Eficacia de la amitriptilina y de la gabapentina
Vidal, M. A., Martinez-Fernandez, E., Morera, L. M. T., & de Castro, J. M. V. (2004) · Dialnet (Universidad de la Rioja) · Cited by 4
Treatment of Painful Diabetic Neuropathy
Boulton, A. J. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-311-0_21 · Cited by 4
Hoyos, E. G., Levy, A. E., Pérez, Á. D., Hernández, M. C., Zorrilla, C. M., & Pascual, A. L. C. (2012) · Seminarios de la Fundación Española de Reumatología · doi:10.1016/j.semreu.2012.06.003 · Cited by 31
Clinical Features of Diabetic Polyneuropathy
Tesfaye, S. H., & Ward, J. D. (1998) · Humana Press eBooks · doi:10.1007/978-1-4612-1816-6_3 · Cited by 4
Self-citationKnobloch, K., & Vogt, P. M. (2011) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e31820e931c · Cited by 4
Alginate dressings for healing diabetic foot ulcers
Dumville, J. C., O’Meara, S., Deshpande, S., & Speak, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009110 · Cited by 6
Klowak, M., Lau, R., Mohammed, M., Birago, A., Samson, B., Ahmed, L., Renee, C., Meconnen, M., Bado, E., Reid-John, A., et al. (2025) · NeuroSci · doi:10.3390/neurosci6030074 · Cited by 3
Facteurs associés à la neuropathie diabétique à l’Hôpital National de Lamordé (Niamey-Niger)
Sani, M., Djibo, I. M., Abdoulkader, A., Madougou, S., Brah, S., Beydou, S. S., Daou, M., Malam-Abdou, B., Adehossi, E. O., & Toure, I. A. (2015) · HEALTH SCIENCES AND DISEASE · doi:10.5281/hsd.v16i4.546 · Cited by 3
Tesfaye, S. H., & Didangelos, T. (2024) · Contemporary diabetes · doi:10.1007/978-3-031-55715-6_3 · Cited by 3
Self-citationAdoukonou, A., Magy, L., Gnonlonfoun, D. D., Gallouëdec, G., Khalil, M., & Vallat, G. (2010) · African Journal of Neurological Sciences · doi:10.4314/ajns.v27i2.55102 · Cited by 3
Perspectivas da terapia com células-tronco para o diabetes mellitus tipo 2
Leal, A. M. O., & Voltarelli, J. C. (2010) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842010005000088 · Cited by 5
Chronic Inflammatory Demyelinating Polyneuropathy in Diabetes Patients
Abraham, A., Alabdali, M. M., Qrimli, M., Barnett, C., Katzberg, H. D., Perkins, B. A., & Bril, V. (2015) · touchREVIEWS in Neurology · doi:10.17925/usn.2015.11.01.47 · Cited by 3
Laway, B., Bijli, A., Rasool, A., Wani, A., Yasir, M., & Bhat, T. A. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_549_16 · Cited by 3
“[2] Peripheral neuropathy (PNP) increases the risk of complications such as foot ulcer and possible amputation resulting in marked economic loss.[3-5] In some developing countries, practice of walking barefoot during extreme weather may predispose to foot injury in patients with diabetes and PNP.”
BackgroundSTUDY OF PREVALENCE AND RISK FACTORS OF PERIPHERAL DIABETIC NEUROPATHY IN A TERTIARY HOSPITAL
Rai, O. N., Mishra, V., Chandra, R. K., Saxena, S., & Mangal, B. (2016) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2016/127 · Cited by 3
Lipid profile as a predictor of Neuropathy: The Sheffield Prospective Diabetes Study
Rajbhandari, S. M., Hamid, F. S., Harris, N. D., & Tesfaye, S. H. (2018) · Journal of Diabetes and Endocrine Association of Nepal · doi:10.3126/jdean.v2i2.22361 · Cited by 3
Self-citationKallinikou, D., Tsentidis, C., Kekou, K., Katsalouli, M., Louraki, M., Kanaka‐Gantenbein, C., Kanavakis, E., & Karavanaki, K. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13285 · Cited by 3
“Probably this association is attributed to the patient's height, as height has been reported to be a significant factor of PDN development, since longer nerve fibers are effected first in the course of DN.33 Similar results have been reported in smaller studies of pediatric patients with T1D.3,36 In line with the abov…”
InfluentialQanita, I., Mardhatillah, G., & Puspita, K. (2021) · RASAYAN Journal of Chemistry · doi:10.31788/rjc.2021.1456469 · Cited by 3
Minor and Major Amputation Rates Following Midfoot Charcot Reconstructive Surgery
Mateen, S., Thomas, M. A., Jappar, A., Meyr, A. J., & Siddiqui, N. A. (2023) · The Journal of Foot & Ankle Surgery · doi:10.1053/j.jfas.2023.07.007 · Cited by 3
Bălașa, R., Bajkó, Z., Maier, S., Voidăzan, S. T., & Moțățăianu, A. (2015) · Acta Marisiensis. Seria Medica · doi:10.1515/amma-2015-0015 · Cited by 3
“Our results are in line with those reported by other authors, namely that the severity of diabetic neuropathy expressed by electrophysiological parameters was significantly related with duration of diabetes mellitus and with metabolic control [18, 19, 20].”
ResultChapter 40 Painful diabetic neuropathies
Boulton, A. J. M. (2006) · Handbook of clinical neurology · doi:10.1016/s0072-9752(06)80044-8 · Cited by 3
Prise en charge de la polyneuropathie diabétique douloureuse
Hartemann, A., Attal, N., Bouhassira, D., Dumont, I., Gin, H., Jeanne, S., Saïd, G., & Richard, J.-L. (2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70072-4 · Cited by 3
Metadata
- Authors
- Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D.
- Affiliations
- Royal Liverpool University Hospital (GB)
- University College London (GB)
- Royal Hallamshire Hospital (GB)
- München Klinik Schwabing (DE)
- IRCCS Ospedale San Raffaele (IT)
- Venue
- Diabetologia
- Published
- 1996-10-23
- Volume
- 39
- Issue
- 11
- Pages
- 1377-1384
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2049568996
- Cited by
- 695
- References
- 30
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 17 · 2023: 30 · 2022: 27 · 2021: 34 · 2020: 32 · 2019: 30 · 2018: 35 · 2017: 23 · 2016: 27 · 2015: 36 · 2014: 41 · 2013: 36 · 2012: 27
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Pfizer
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diabetic peripheral neuropathy, prevalence, type 1 diabetes, glycemic control, risk factors, diabetes duration, diabetic retinopathy, smoking, HDL cholesterol, cardiovascular disease, diastolic blood pressure, ketoacidosis, fasting triglycerides, microalbuminuria, autonomic dysfunction, erectile dysfunction, alcohol consumption
- MeSH terms
- Adolescent, Adult, Blood Pressure, Body Constitution, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Diabetic Retinopathy, Europe, Female, Humans, Hypoglycemia, Lipids, Male, Middle Aged, Peripheral Nervous System Diseases, Regression Analysis, Risk Factors, Smoking, Body Mass Index, Prevalence, Diabetic Ketoacidosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.